非病毒-话题@MedSci - 梅斯（MedSci）

#非病毒#

10篇内容 | 610人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1819567, encodeId=0fa2181956e4e, content=<a href='/topic/show?id=7df79956800' target=_blank style='color:#2F92EE;'>#非病毒#</a>, objectTitle=medRxiv：世界首例PD1敲除非病毒定点整合CART治疗淋巴瘤取得突破性成果, objectType=article, longId=201270, objectId=3ae92012e040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ae92012e040, replyNumber=0, likeNumber=70, createdTime=2021-01-05, rootId=0, userName=zhao4616, userId=ba5f232, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ae92012e040, moduleTitle=medRxiv：世界首例PD1敲除非病毒定点整合CART治疗淋巴瘤取得突破性成果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3ae92012e040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819566, encodeId=2230181956621, content=<a href='/topic/show?id=7df79956800' target=_blank style='color:#2F92EE;'>#非病毒#</a>, objectTitle=FDA授予Precigen公司的非病毒多基因CAR-T疗法PRGN-3006孤儿药指定，用于治疗急性髓细胞性白血病, objectType=article, longId=185922, objectId=f2591859220a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2591859220a, replyNumber=0, likeNumber=0, createdTime=2020-06-08, rootId=0, userName=zhao4616, userId=ba5f232, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2591859220a, moduleTitle=FDA授予Precigen公司的非病毒多基因CAR-T疗法PRGN-3006孤儿药指定，用于治疗急性髓细胞性白血病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f2591859220a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819565, encodeId=af281819565ad, content=<a href='/topic/show?id=7df79956800' target=_blank style='color:#2F92EE;'>#非病毒#</a>, objectTitle=非病毒性肝炎发病升高已成国民健康“潜伏杀手”, objectType=article, longId=176409, objectId=c22b1e64093d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c22b1e64093d, replyNumber=0, likeNumber=102, createdTime=2019-09-04, rootId=0, userName=zhao4616, userId=ba5f232, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c22b1e64093d, moduleTitle=非病毒性肝炎发病升高已成国民健康“潜伏杀手”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c22b1e64093d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819564, encodeId=fe751819564ee, content=<a href='/topic/show?id=7df79956800' target=_blank style='color:#2F92EE;'>#非病毒#</a>, objectTitle=国内首家非病毒载体CAR-T细胞治疗产品获批临床, objectType=article, longId=164209, objectId=53ae164209ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53ae164209ad, replyNumber=0, likeNumber=71, createdTime=2019-06-13, rootId=0, userName=zhao4616, userId=ba5f232, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53ae164209ad, moduleTitle=国内首家非病毒载体CAR-T细胞治疗产品获批临床, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=53ae164209ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819563, encodeId=d15f1819563dc, content=<a href='/topic/show?id=7df79956800' target=_blank style='color:#2F92EE;'>#非病毒#</a>, objectTitle=Blood：非病毒RNA转导的CART19细胞治疗复发/难治性霍奇金淋巴瘤安全可行, objectType=article, longId=148840, objectId=8e981488405a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e981488405a, replyNumber=0, likeNumber=89, createdTime=2019-05-13, rootId=0, userName=zhao4616, userId=ba5f232, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e981488405a, moduleTitle=Blood：非病毒RNA转导的CART19细胞治疗复发/难治性霍奇金淋巴瘤安全可行, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8e981488405a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819561, encodeId=fd5e1819561e4, content=<a href='/topic/show?id=7df79956800' target=_blank style='color:#2F92EE;'>#非病毒#</a>, objectTitle=Blood：非病毒RNA嵌合抗原受体修饰的T细胞用于霍奇金淋巴瘤患者的疗效和安全性, objectType=article, longId=141232, objectId=07e8141232cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07e8141232cc, replyNumber=0, likeNumber=62, createdTime=2018-12-21, rootId=0, userName=zhao4616, userId=ba5f232, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07e8141232cc, moduleTitle=Blood：非病毒RNA嵌合抗原受体修饰的T细胞用于霍奇金淋巴瘤患者的疗效和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=07e8141232cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819560, encodeId=47e6181956082, content=<a href='/topic/show?id=7df79956800' target=_blank style='color:#2F92EE;'>#非病毒#</a>, objectTitle=Eur Cell Mater：通过非病毒基因递送BMP-2/6和BMP-2/7形成异二聚体促进骨生成, objectType=article, longId=134167, objectId=01b113416edf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01b113416edf, replyNumber=0, likeNumber=76, createdTime=2018-05-27, rootId=0, userName=zhao4616, userId=ba5f232, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01b113416edf, moduleTitle=Eur Cell Mater：通过非病毒基因递送BMP-2/6和BMP-2/7形成异二聚体促进骨生成, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=01b113416edf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819562, encodeId=b257181956261, content=<a href='/topic/show?id=7df79956800' target=_blank style='color:#2F92EE;'>#非病毒#</a>, objectTitle=NATURE：非病毒基因组靶向重编程人类T细胞, objectType=article, longId=144310, objectId=f93414431095, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f93414431095, replyNumber=0, likeNumber=124, createdTime=2019-01-21, rootId=0, userName=zhao4616, userId=ba5f232, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f93414431095, moduleTitle=NATURE：非病毒基因组靶向重编程人类T细胞, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f93414431095)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819559, encodeId=186118195594f, content=<a href='/topic/show?id=7df79956800' target=_blank style='color:#2F92EE;'>#非病毒#</a>, objectTitle=NAT NANOTECHNOL：纳米转染介导非病毒基因重编程, objectType=article, longId=108052, objectId=e67a108052c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e67a108052c4, replyNumber=0, likeNumber=83, createdTime=2017-12-18, rootId=0, userName=zhao4616, userId=ba5f232, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e67a108052c4, moduleTitle=NAT NANOTECHNOL：纳米转染介导非病毒基因重编程, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e67a108052c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819558, encodeId=63281819558e4, content=<a href='/topic/show?id=7df79956800' target=_blank style='color:#2F92EE;'>#非病毒#</a>, objectTitle=Human Gene Therapy：非病毒基因载体技术治疗B细胞淋巴瘤研究进展, objectType=article, longId=85798, objectId=9f9f85e98e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f9f85e98e9, replyNumber=0, likeNumber=72, createdTime=2017-03-17, rootId=0, userName=zhao4616, userId=ba5f232, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f9f85e98e9, moduleTitle=Human Gene Therapy：非病毒基因载体技术治疗B细胞淋巴瘤研究进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9f9f85e98e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

非病毒

2020-05-29

zhao4616 (审核中...)

前往app查看评论内容

#非病毒#

medRxiv：世界首例PD1敲除非病毒定点整合CART治疗淋巴瘤取得突破性成果

2021-01-05

zhao4616 (审核中...)

前往app查看评论内容

#非病毒#

FDA授予Precigen公司的非病毒多基因CAR-T疗法PRGN-3006孤儿药指定，用于治疗急性髓细胞性白血病

2020-06-08

zhao4616 (审核中...)

前往app查看评论内容

#非病毒#

非病毒性肝炎发病升高已成国民健康“潜伏杀手”

2019-09-04

zhao4616 (审核中...)

前往app查看评论内容

#非病毒#

国内首家非病毒载体CAR-T细胞治疗产品获批临床

2019-06-13

zhao4616 (审核中...)

前往app查看评论内容

#非病毒#

Blood：非病毒RNA转导的CART19细胞治疗复发/难治性霍奇金淋巴瘤安全可行

2019-05-13

zhao4616 (审核中...)

前往app查看评论内容

#非病毒#

Blood：非病毒RNA嵌合抗原受体修饰的T细胞用于霍奇金淋巴瘤患者的疗效和安全性

2018-12-21

zhao4616 (审核中...)

前往app查看评论内容

#非病毒#

Eur Cell Mater：通过非病毒基因递送BMP-2/6和BMP-2/7形成异二聚体促进骨生成

2018-05-27

zhao4616 (审核中...)

前往app查看评论内容

#非病毒#

NATURE：非病毒基因组靶向重编程人类T细胞

2019-01-21

zhao4616 (审核中...)

前往app查看评论内容

#非病毒#

NAT NANOTECHNOL：纳米转染介导非病毒基因重编程

2017-12-18

zhao4616 (审核中...)

前往app查看评论内容

#非病毒#

Human Gene Therapy：非病毒基因载体技术治疗B细胞淋巴瘤研究进展

2017-03-17

科室
- - 订阅+
  - 更多科室
工具
服务